KURA - Kura Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development46,78726,42620,40417,777
Selling General and Administrative16,0969,6517,9636,088
Non Recurring----
Total Operating Expenses62,88336,07728,36723,865
Operating Income or Loss-62,883-36,077-28,367-23,865
Income from Continuing Operations
Total Other Income/Expenses Net2,4366438071,240
Earnings Before Interest and Taxes-62,883-36,077-28,367-23,865
Interest Expense-970-888-577-88
Income Before Tax-60,447-35,434-27,560-22,625
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-60,447-35,434-27,560-22,625
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-60,447-35,434-27,560-22,625
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-60,447-35,434-27,560-22,625